A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
Saved in:
| Title: | A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting. |
|---|---|
| Authors: | Hicks SM; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Pohl K; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.; Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany., Neeman T; Biological Data Science Institute, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., McNamara HA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Parsons KM; Australian National University Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia., He JS; Australian National University Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia., Ali SA; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Nazir S; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Rowntree LC; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia., Nguyen THO; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia., Kedzierska K; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia., Doolan DL; Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia., Vinuesa CG; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.; China Australia Centre for Personalised Immunology, Shanghai Renji Hospital, Jiaotong University, Shanghai, China.; Department of Immunology Canberra Hospital, Canberra, Australia., Cook MC; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.; Department of Immunology Canberra Hospital, Canberra, Australia., Coatsworth N; ANU Medical School, Australian National University, Canberra, Australia.; The Canberra Hospital, Infectious Diseases, Canberra, Australia., Myles PS; Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital, Melbourne, Australia.; Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, Australia., Kurth F; Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany.; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine.; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany., Mann GJ; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Gruen RL; College of Health and Medicine, The Australian National University, Canberra, Australia., George AJ; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.; Australian National University Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia., Gardiner EE; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Cockburn IA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia. |
| Corporate Authors: | SARS-CoV-2 Testing in Elective Surgery Collaborators |
| Source: | The Journal of infectious diseases [J Infect Dis] 2021 Jan 04; Vol. 223 (1), pp. 10-14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiaa623 |
